This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sloan-Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 519 
1 out of 621 
Years Active: 2012-2025
Title: Innovations of Inventor Kai Deng
Introduction
Kai Deng is a notable inventor based in Guilderland, NY (US), recognized for his contributions to the field of immunology. He holds a total of five patents, showcasing his innovative approach to developing new adjuvants for vaccines.
Latest Patents
One of his latest patents focuses on triterpene saponins, methods of synthesis, and their uses. This invention relates to triterpene glycoside saponin-derived adjuvants, including the synthesis and intermediates involved. Notably, QS-7, a potent immuno-adjuvant developed by Deng, is significantly less toxic than QS-21, a related saponin currently favored in anticancer and antiviral vaccines. The tedious isolation and purification protocols have previously hindered the clinical development of QS-7. However, Deng's novel semi-synthetic method utilizes a hydrolyzed prosapogenin mixture to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to these compounds for preclinical and clinical evaluation.
Career Highlights
Throughout his career, Kai Deng has worked with prestigious institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. His work has significantly impacted the development of new therapeutic strategies in cancer treatment.
Collaborations
Deng has collaborated with
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile